Apiotix Technologies

logo Apiotix

Technology

ApiMast

Apiotix Technologies focuses on developing and commercializing a proprietary technology for the extraction and standardization of one of the most potent natural products out there – propolis. Our active pharmaceutical ingredient (API) is a standardized propolis extract (SPE), suitable for pharmaceutical dosage forms, cosmetics, food, and agriculture.

It is patented under publication No. WO/2020/169425, LIQUID PROPOLIS EXTRACT, ITS FORMULATION AND USE THEREOF.

Our reliable sources of raw material and patented extraction and standardization method are the key factors of our innovative quality. These come from a great experience in chemistry and pharmacology of natural compounds, especially honeybee products.

Our products are derived from bee products via a standardized extraction & purification process

POLLEN RAW

RAW PRODUCTS

POLLEN

POLLEN

INTERMEDIATE PRODUCT

POLLEN

Propolis

RAW PRODUCTS

PROPOLIS

propolis

INTERMEDIATE PRODUCT

PROPOLIS

ApiMast

ApiPhenocomplex

Key take-aways:

  • Liquid extract with standardized content of bioactive compounds
  • Broad spectrum antimicrobial efficacy 
  • Efficacy against multidrug resistant pathogens & biofilm
  • Potent antioxidant effect
  • Alternative to antibiotics  with minimum risk of resistance development 
  • Potential of translation to human medicine
ApiMast

ApiPhenocomplex

Key take-aways:

- Liquid extract with standardized content of bioactive compounds

- Broad spectrum antimicrobial efficacy 

- Efficacy against multidrug resistant pathogens & biofilm

- Potent antioxidant effect

- Alternative to antibiotics  with minimum risk of resistance development 

- Potential of translation to human medicine

collection of raw material – physical separation – chemical purification – quality control